Sort
51,593 grants matching “hepatitis”
Homeostatic Responses to Amino Acid Insufficiency
$669,484Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2023 · DK
Administrative Core
$669,465Craig J McClain · University Of Louisville · P20 · FY2016 · GM
Prolonged Daily Fasting As a Viable Alternative to Caloric Restriction in At-Risk Obese Humans
$669,417Lisa Senye Chow · University Of Minnesota · R01 · FY2023 · DK
International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study
$669,307Lewis R Roberts · Mayo Clinic Rochester · U01 · FY2025 · CA
Cell Type Specific Roles of ApoE2 in Tissue Inflammation and Atherosclerosis
$669,252David Y Hui · University Of Cincinnati · R01 · FY2016 · HL
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS
$669,213Nathan Oliver Stitziel · Washington University · R01 · FY2019 · HL
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS
$669,213Nathan Oliver Stitziel · Washington University · R01 · FY2018 · HL
Vault-CCL21 Nanocapsule for Lung Cancer
$669,156Indresh K Srivastava · Protein Sciences Corporation · U44 · FY2014 · CA
Mechanisms of insulin resistance related to nonalcoholic steatohepatitis
$669,131Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · DK
Mechanisms of insulin resistance related to nonalcoholic steatohepatitis
$669,131Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · DK
Mechanisms of insulin resistance related to nonalcoholic steatohepatitis
$669,131Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · DK
Mechanisms of insulin resistance related to nonalcoholic steatohepatitis
$669,131Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · DK
Iron Status: A Pathway Analysis in Multiple Ethnicities
$669,129Christine E McLaren · University Of California-Irvine · R01 · FY2008 · HL
Thrombopoietin Targeting in Myeloproliferative Neoplasms
$669,111Christina U Lorentz · Aronora, Inc. · R44 · FY2024 · HL
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
$669,100Arash Grakoui · Emory University · R01 · FY2022 · AI
The role of liver progenitor cells in liver regeneration
$669,086Wolfram Goessling · Brigham And Women'S Hospital · R01 · FY2023 · DK
The application of human collagen kinetic biomarkers to anti-fibrotic drug develo
$669,082Scott M Turner · Kinemed, Inc. · R44 · FY2010 · CA
Risk Factors for Venous Thromboembolism in the Community
$669,010John A Heit · Mayo Clinic Rochester · R01 · FY2014 · HL
Sensitive Detection of Bacterial Contamination in Platelets
$668,954Season S-S Wong · Lynntech, Inc. · R44 · FY2008 · HL
Accelerating novel countermeasures against RNA viruses through repurposing
$668,817Shirit Einav · Stanford University · U19 · FY2018 · AI
The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases
$668,781Arya Mani · Yale University · R01 · FY2024 · DK
Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
$668,778Joshua T Herbeck · University Of Washington · R01 · FY2017 · DA
Pathophysiologic mechanisms leading to intrahepatic fat accumulation in obese youth
$668,756Nicola Santoro · Yale University · R01 · FY2021 · MD
Novel Endocrine Actions of Myostatin; Impacts on Somatomediation
$668,747Buel D Rodgers · Washington State University · · FY2012 · BIO
Profiling the protective B cell response to HCV
$668,744Steven Foung · Stanford University · U19 · FY2020 · AI